α-Ketoglutarate (α-KG) Analysis — LC-MS/MS Quantification for IDH Mutation & Epigenetic Research
α-Ketoglutarate is not a generic TCA cycle intermediate — it is the obligatory co-substrate for over 60 α-KG-dependent dioxygenases, including the TET family of DNA demethylases, the JmjC domain-containing histone demethylases, and the prolyl hydroxylases that regulate HIF-1α stability. In IDH1/2-mutant cancers, neomorphic enzymatic activity diverts α-KG to the oncometabolite D-2-hydroxyglutarate — making the α-KG concentration a direct readout of mutant IDH activity. Our HILIC LC-MS/MS method quantifies α-KG with 13C5-α-ketoglutarate as stable isotope internal standard, providing absolute concentrations from cells, tissues, and biofluids. The same injection can be extended to D-2-HG, succinate, fumarate, and the full TCA cycle panel.
Absolute quantification by stable isotope dilution — 13C5-α-ketoglutarate IS, HILIC chromatography, MRM detection on SCIEX QTRAP 6500+
Direct readout for IDH1/2 mutation activity — α-KG/D-2-HG ratio from the same sample, same injection
Dioxygenase co-substrate context — TET, JmjC, and PHD enzyme activity is directly limited by α-KG availability and competitively inhibited by succinate and fumarate



